The tumor growth rate and hepatic metastasis of CCL5−/− mice were increased after S100a9 treatment compared to CCL5−/− mice treated with PBS (Fig. 4e and Supplementary Fig. 11). The gene discussed is CCL5; the disease is neoplasm.